AKT1 and neoplasm: Among these molecular targets, the phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin inhibitor (mTOR) pathway has proved to be an indispensable driving signaling and associated with tumor progression, treatment response, and clinical outcomes in many types of tumors.